Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$225K |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$208K |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$176K |
| 4 |
Tesla
TSLA
|
+$176K |
| 5 |
Meta Platforms (Facebook)
META
|
+$174K |
Top Sells
| 1 |
TECD
Tech Data Corp
TECD
|
+$186M |
| 2 |
MINI
Mobile Mini Inc
MINI
|
+$92.3M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$91.9M |
| 4 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$77.9M |
| 5 |
Kraft Heinz
KHC
|
+$60.1M |
Sector Composition
| 1 | Healthcare | 15.67% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Technology | 11.33% |
| 4 | Industrials | 10.91% |
| 5 | Financials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBK
3076
DELISTED
Westpac Banking Corporation
WBK
| $262 | ﹤0.01% |
+21,777
| New | +$262 |
|
3077
Braskem
BAK
$1.34B
| $262 | ﹤0.01% |
35,009
-185,708
| -84% | -$1.39K |
|
|
SOL
3078
Emeren Group
SOL
$95.5M
| $262 | ﹤0.01% |
+126,706
| New | +$262 |
|
|
CNTG
3079
DELISTED
Centogene N.V. Common Shares
CNTG
| $261 | ﹤0.01% |
+27,612
| New | +$261 |
|
3080
Methanex
MEOH
$3.08B
| $260 | ﹤0.01% |
10,645
-33,782
| -76% | -$825 |
|
|
ATCO
3081
DELISTED
Atlas Corp.
ATCO
| $260 | ﹤0.01% |
29,062
+9,328
| +47% | +$83 |
|
3082
Mercantile Bank Corp
MBWM
$785M
| $259 | ﹤0.01% |
14,378
+1,810
| +14% | +$33 |
|
3083
PAR Technology
PAR
$1.86B
| $259 | ﹤0.01% |
6,390
-27,722
| -81% | -$1.12K |
|
3084
IDT Corp
IDT
$1.65B
| $258 | ﹤0.01% |
39,171
+22,383
| +133% | +$147 |
|
3085
NewMarket
NEU
$7.98B
| $258 | ﹤0.01% |
754
-3,276
| -81% | -$1.12K |
|
3086
Nokia
NOK
$24.9B
| $258 | ﹤0.01% |
66,051
-3,508,693
| -98% | -$13.7K |
|
3087
Talphera
TLPH
$20.4M
| $258 | ﹤0.01% |
+9,087
| New | +$258 |
|
3088
SmartFinancial
SMBK
$637M
| $258 | ﹤0.01% |
+19,016
| New | +$258 |
|
|
AXDX
3089
DELISTED
Accelerate Diagnostics
AXDX
| $257 | ﹤0.01% |
2,411
+66
| +3% | +$7 |
|
|
BCYC
3090
Bicycle Therapeutics
BCYC
$487M
| $257 | ﹤0.01% |
13,481
-4,833
| -26% | -$92 |
|
3091
Resources Connection
RGP
$170M
| $257 | ﹤0.01% |
+22,274
| New | +$257 |
|
|
VIVO
3092
DELISTED
Meridian Bioscience Inc
VIVO
| $257 | ﹤0.01% |
15,150
-666,074
| -98% | -$11.3K |
|
|
ETTX
3093
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $257 | ﹤0.01% |
+125,848
| New | +$257 |
|
3094
BJ's Restaurants
BJRI
$716M
| $256 | ﹤0.01% |
+8,697
| New | +$256 |
|
|
GRX
3095
Gabelli Healthcare & Wellness Trust
GRX
$146M
| $256 | ﹤0.01% |
+24,786
| New | +$256 |
|
3096
Xeris Biopharma Holdings
XERS
$1.24B
| $256 | ﹤0.01% |
43,220
-461,023
| -91% | -$2.73K |
|
3097
Minerva Neurosciences
NERV
$14.9M
| $255 | ﹤0.01% |
10,027
+6,805
| +211% | +$173 |
|
3098
Dianthus Therapeutics
DNTH
$1.22B
| $254 | ﹤0.01% |
2,333
-15,180
| -87% | -$1.65K |
|
3099
Northrim BanCorp
NRIM
$509M
| $254 | ﹤0.01% |
9,966
+718
| +8% | +$18 |
|
3100
Pure Cycle
PCYO
$272M
| $254 | ﹤0.01% |
28,203
-74,365
| -73% | -$670 |
|